Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05154773 · ClinicalTrials.gov registry record · NA
Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication
A NA study of End Stage Renal Disease and Chronic Kidney Diseases, sponsored by State University of New York at Buffalo.
- Active
- Registry status
- NA
- Development phase
- 422
- Enrollment target
- 1
- Study location
NCT05154773: Active NA study of End Stage Renal Disease and Chronic Kidney Diseases, sponsored by State University of New York at Buffalo.
NCT05154773 is a NA study of End Stage Renal Disease and Chronic Kidney Diseases that is active but no longer recruiting, run by State University of New York at Buffalo. The registered enrollment target is 422 participants, below the 829-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05154773, a NA study of End Stage Renal Disease and Chronic Kidney Diseases, is active but no longer recruiting, sponsored by State University of New York at Buffalo.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 422 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a- 2-arm randomized controlled trial among patients presenting for kidney transplant evaluation at a single transplant center to compare the effects of a patient-based self-learning and outreach intervention about living-donor kidney transplantation (KidneyTIME) versus usual care for living-donor kidney transplant knowledge, concerns, readiness, access behaviors, and living-donor inquiries over 12 months follow-up. Following consent and baseline assessment, participants were randomized, stratified by self-reported race, with equal allocation to 2 treatment arms: the KidneyTIME intervention and usual care.
Primary Outcome
Living donor inquiry to the transplant center on behalf of the participant by telephone, email, or mail within 12 months from enrollment. Each inquiry is captured for all patients as a discrete field in the electronic medical record within 12 months from enrollment. An inquiry includes any request for information or evaluation to be a living kidney donor in which the recipients' name is specified.
Conditions Studied
Interventions
- BEHAVIORAL Kidney donation and transplant information made easy
Study Locations (1)
New York
- Erie County Medical Center - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 422 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
What the registry record for NCT05154773 still lists
NCT05154773 is an interventional study that assigns participants to a tested intervention. The registered 422 participants enrollment target is mid-sized for trials with a published cap, below the 829-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (49% lower).
The record links to 2 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 1 intervention - of which Kidney donation and transplant information made easy is the first listed.
NCT05154773 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05154773 about?
NCT05154773 is a clinical study titled "Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication". The study is a- 2-arm randomized controlled trial among patients presenting for kidney transplant evaluation at a single transplant center to compare the effects of a patient-based self-learning and outreach intervention about living-donor kidney transplantation (KidneyTIME) versus usual care for li...
What is the current status of trial NCT05154773?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 422 participants. The study started on 2022-04-01. Estimated completion is 2026-03-30.
What conditions does trial NCT05154773 study?
This clinical trial studies the following conditions: End Stage Renal Disease, Chronic Kidney Diseases.
What interventions are being tested in trial NCT05154773?
The interventions under investigation include: Kidney donation and transplant information made easy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05154773?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05154773 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05154773's enrollment target sits among peer trials
422 14th of 86 higher than 73 of 86 other End Stage Renal Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Renal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
RECRUITING · NA
-
CAPABLE Transplant
RECRUITING · NA
-
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04763356 · 422 participants · NA
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
- NCT06837246 · 422 participants · NA
A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population
- NCT07298967 · 422 participants · NA
ORCHARDS-AIR Study
- NCT06935591 · 423 participants · NA
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI